Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | DHCR24 | Q15392 | 8/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | VDR | P11473 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28364466 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL14419156 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL29592490 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL1703700 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL10149106 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL6900716 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL665862 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL21748185 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL22150349 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL18109189 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120046265-A1 | USE OF ERGOSTA-7,22-DIEN-3beta-OL IN THE TREATMENT OF CANCER | VITA GREEN BIOTECHNOLOGY CO. LIMITED (HK) | 2012-02-23 | — | — | US | disclosed |
| US-20120046265-A1 | USE OF ERGOSTA-7,22-DIEN-3beta-OL IN THE TREATMENT OF CANCER | VITA GREEN BIOTECHNOLOGY CO. LIMITED (HK) | 2012-02-23 | — | — | US | disclosed |
| US-20090247497-A1 | FORMULATION AND USE OF ERGOSTA-7,22-DIEN-3BETA-OL | VITA GREEN BIOTECHNOLOGY CO. LIMITED (HK) | 2009-10-01 | — | — | US | disclosed |
| US-20090247497-A1 | FORMULATION AND USE OF ERGOSTA-7,22-DIEN-3BETA-OL | VITA GREEN BIOTECHNOLOGY CO. LIMITED (HK) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247497-A1 | FORMULATION AND USE OF ERGOSTA-7,22-DIEN-3BETA-OL | ERG28, HSD3B2, CYP51A1 | TRPV1 4679/4885CYP3A4 406/4885DHCR24 324/4885 |
| US-20120046265-A1 | USE OF ERGOSTA-7,22-DIEN-3beta-OL IN THE TREATMENT OF CANCER | ERG28, HSD3B2, ERG | TRPV1 4875/4885CYP3A4 926/4885DHCR24 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.